Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Cytokines in Male Fertility and Reproductive Pathologies: Immunoregulation and Beyond.

Loveland KL, Klein B, Pueschl D, Indumathy S, Bergmann M, Loveland BE, Hedger MP, Schuppe HC.

Front Endocrinol (Lausanne). 2017 Nov 20;8:307. doi: 10.3389/fendo.2017.00307. eCollection 2017. Review.

2.

An in vitro model demonstrates the potential of neoplastic human germ cells to influence the tumour microenvironment.

Klein B, Schuppe HC, Bergmann M, Hedger MP, Loveland BE, Loveland KL.

Andrology. 2017 Jul;5(4):763-770. doi: 10.1111/andr.12365. Epub 2017 May 23.

3.

A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer.

Mitchell PL, Quinn MA, Grant PT, Allen DG, Jobling TW, White SC, Zhao A, Karanikas V, Vaughan H, Pietersz G, McKenzie IF, Gargosky SE, Loveland BE.

J Immunother Cancer. 2014 Jun 18;2:16. doi: 10.1186/2051-1426-2-16. eCollection 2014.

4.

Induction of multi-functional T cells in a phase I clinical trial of dendritic cell immunotherapy in hepatitis C virus infected individuals.

Li S, Roberts S, Plebanski M, Gouillou M, Spelman T, Latour P, Jackson D, Brown L, Sparrow RL, Prince HM, Hart D, Loveland BE, Gowans EJ.

PLoS One. 2012;7(8):e39368. doi: 10.1371/journal.pone.0039368. Epub 2012 Aug 14.

5.

Anti-Pim-1 mAb inhibits activation and proliferation of T lymphocytes and prolongs mouse skin allograft survival.

Li J, Loveland BE, Xing PX.

Cell Immunol. 2011;272(1):87-93. doi: 10.1016/j.cellimm.2011.09.002. Epub 2011 Sep 17.

PMID:
21974958
6.

Analysis of FOXP3+ regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection.

Li S, Floess S, Hamann A, Gaudieri S, Lucas A, Hellard M, Roberts S, Paukovic G, Plebanski M, Loveland BE, Aitken C, Barry S, Schofield L, Gowans EJ.

PLoS Pathog. 2009 Dec;5(12):e1000707. doi: 10.1371/journal.ppat.1000707. Epub 2009 Dec 24. Erratum in: PLoS Pathog. 2012 Jun;8(6). doi:10.1371/annotation/523d94fe-9730-499b-95b1-addd94089ff8.

7.

Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets.

van der Windt DJ, Bottino R, Casu A, Campanile N, Smetanka C, He J, Murase N, Hara H, Ball S, Loveland BE, Ayares D, Lakkis FG, Cooper DK, Trucco M.

Am J Transplant. 2009 Dec;9(12):2716-26. doi: 10.1111/j.1600-6143.2009.02850.x. Epub 2009 Oct 21.

8.

Pim-1 expression and monoclonal antibody targeting in human leukemia cell lines.

Li J, Hu XF, Loveland BE, Xing PX.

Exp Hematol. 2009 Nov;37(11):1284-94. doi: 10.1016/j.exphem.2009.08.002. Epub 2009 Aug 21.

PMID:
19703513
9.

The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunity.

van Spriel AB, Sofi M, Gartlan KH, van der Schaaf A, Verschueren I, Torensma R, Raymakers RA, Loveland BE, Netea MG, Adema GJ, Wright MD, Figdor CG.

PLoS Pathog. 2009 Mar;5(3):e1000338. doi: 10.1371/journal.ppat.1000338. Epub 2009 Mar 13.

10.

Cancer exploiting complement: a clue or an exception?

Loveland BE, Cebon J.

Nat Immunol. 2008 Nov;9(11):1205-6. doi: 10.1038/ni1108-1205. No abstract available.

PMID:
18936777
11.

Human dendritic cells pulsed with specific lipopeptides stimulate autologous antigen-specific T cells without the addition of exogenous maturation factors.

Jones KL, Brown LE, Eriksson EM, Ffrench RA, Latour PA, Loveland BE, Wall DM, Roberts SK, Jackson DC, Gowans EJ.

J Viral Hepat. 2008 Oct;15(10):761-72. doi: 10.1111/j.1365-2893.2008.01003.x. Epub 2008 Jul 10.

PMID:
18637077
12.

Dendritic cell vaccination.

Proudfoot O, Pouniotis D, Sheng KC, Loveland BE, Pietersz GA.

Expert Rev Vaccines. 2007 Aug;6(4):617-33. Review.

PMID:
17669014
13.

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835].

Apostolopoulos V, Pietersz GA, Tsibanis A, Tsikkinis A, Drakaki H, Loveland BE, Piddlesden SJ, Plebanski M, Pouniotis DS, Alexis MN, McKenzie IF, Vassilaros S.

Breast Cancer Res. 2006;8(3):R27. Epub 2006 Jun 15.

14.

Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses.

Apostolopoulos V, Pouniotis DS, van Maanen PJ, Andriessen RW, Lodding J, Xing PX, McKenzie IF, Loveland BE, Pietersz GA.

Vaccine. 2006 Apr 12;24(16):3191-202. Epub 2006 Jan 25.

PMID:
16480791
15.

Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma.

Loveland BE, Zhao A, White S, Gan H, Hamilton K, Xing PX, Pietersz GA, Apostolopoulos V, Vaughan H, Karanikas V, Kyriakou P, McKenzie IF, Mitchell PL.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):869-77.

16.

Novel role for decay-accelerating factor in coxsackievirus A21-mediated cell infectivity.

Newcombe NG, Beagley LG, Christiansen D, Loveland BE, Johansson ES, Beagley KW, Barry RD, Shafren DR.

J Virol. 2004 Nov;78(22):12677-82.

17.

Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.

Loveland BE, Milland J, Kyriakou P, Thorley BR, Christiansen D, Lanteri MB, Regensburg M, Duffield M, French AJ, Williams L, Baker L, Brandon MR, Xing PX, Kahn D, McKenzie IF.

Xenotransplantation. 2004 Mar;11(2):171-83.

PMID:
14962279
18.

CD46 protects pig islets from antibody but not cell-mediated destruction in the mouse.

McKenzie IF, Li YQ, Xing PX, Dinatale I, Koulmanda M, Loveland BE, Sandrin MS.

Xenotransplantation. 2003 Nov;10(6):615-21.

PMID:
14708531
19.

Ligand binding determines whether CD46 is internalized by clathrin-coated pits or macropinocytosis.

Crimeen-Irwin B, Ellis S, Christiansen D, Ludford-Menting MJ, Milland J, Lanteri M, Loveland BE, Gerlier D, Russell SM.

J Biol Chem. 2003 Nov 21;278(47):46927-37. Epub 2003 Sep 3.

20.

Aspects of cancer immunotherapy.

McKenzie IF, Apostolopoulos V, Plebanski M, Pietersz GA, Loveland BE.

Immunol Cell Biol. 2003 Feb;81(1):79-85.

PMID:
12534951
21.

Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46).

Giannakis E, Jokiranta TS, Ormsby RJ, Duthy TG, Male DA, Christiansen D, Fischetti VA, Bagley C, Loveland BE, Gordon DL.

J Immunol. 2002 May 1;168(9):4585-92.

22.

Genetic engineering for xenotransplantation.

Sandrin MS, Loveland BE, McKenzie IF.

J Card Surg. 2001 Nov-Dec;16(6):448-57. Review.

PMID:
11925025
23.

A functional interaction between CD46 and DLG4: a role for DLG4 in epithelial polarization.

Ludford-Menting MJ, Thomas SJ, Crimeen B, Harris LJ, Loveland BE, Bills M, Ellis S, Russell SM.

J Biol Chem. 2002 Feb 8;277(6):4477-84. Epub 2001 Nov 19.

24.

A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions.

Spendlove L, Li L, Potter V, Christiansen D, Loveland BE, Durrant LG.

Eur J Immunol. 2000 Oct;30(10):2944-53.

25.

Are pigs transgenic for human complement regulatory proteins necessary for xenotransplantation?

Loveland BE, Cooper DK, Sandrin MS.

Transplantation. 2000 Aug 27;70(4):567-8. No abstract available.

PMID:
10972209
26.

Inhibition of hyperacute transplant rejection by soluble proteins with the functional domains of CD46 and FcgammaRII.

Lanteri MB, Powell MS, Christiansen D, Li YQ, Hogarth M, Sandrin MS, Mckenzie IF, Loveland BE.

Transplantation. 2000 Mar 27;69(6):1128-36.

PMID:
10762218
27.

Current and future prospects for xenotransplantation.

French AJ, Greenstein JL, Loveland BE, Mountford PS.

Reprod Fertil Dev. 1998;10(7-8):683-96. Review.

PMID:
10612477
28.
29.

Transgenic expression of a CD46 (membrane cofactor protein) minigene: studies of xenotransplantation and measles virus infection.

Thorley BR, Milland J, Christiansen D, Lanteri MB, McInnes B, Moeller I, Rivailler P, Horvat B, Rabourdin-Combe C, Gerlier D, McKenzie IF, Loveland BE.

Eur J Immunol. 1997 Mar;27(3):726-34.

PMID:
9079815
30.

Translation is enhanced after silent nucleotide substitutions in A+T- rich sequences of the coding region of CD46 cDNA.

Milland J, Christiansen D, Thorley BR, McKenzie IF, Loveland BE.

Eur J Biochem. 1996 May 15;238(1):221-30.

31.

Engineering of recombinant soluble CD46: an inhibitor of complement activation.

Christiansen D, Milland J, Thorley BR, McKenzie IF, Mottram PL, Purcell LJ, Loveland BE.

Immunology. 1996 Mar;87(3):348-54.

32.

A functional analysis of recombinant soluble CD46 in vivo and a comparison with recombinant soluble forms of CD55 and CD35 in vitro.

Christiansen D, Milland J, Thorley BR, McKenzie IF, Loveland BE.

Eur J Immunol. 1996 Mar;26(3):578-85.

PMID:
8605924
33.

CTL in mice immunized with human mucin 1 are MHC-restricted.

Apostolopoulos V, Loveland BE, Pietersz GA, McKenzie IF.

J Immunol. 1995 Dec 1;155(11):5089-94.

PMID:
7594517
34.

Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses.

Apostolopoulos V, Pietersz GA, Loveland BE, Sandrin MS, McKenzie IF.

Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10128-32.

35.

Hepatic portal infiltrates in mice immunized with syngeneic lymphoid cells: connotations for models of autoimmune liver disease.

Karanikas V, MacKay IR, Rowley MJ, Veitch B, Loveland BE.

J Gastroenterol Hepatol. 1995 Sep-Oct;10(5):491-7.

PMID:
8963023
36.

Construction of CD46 minigenes for the production of transgenic mice.

Thorley BR, McInnes B, Christiansen D, McKenzie IF, Loveland BE.

Transplant Proc. 1995 Jun;27(3):2177-8. No abstract available.

PMID:
7792924
37.
38.

Tissue-specific expression of CD46 protein isoforms due to production of RNA splice variants.

Johnstone RW, Russell S, Loveland BE, McKenzie IF.

Transplant Proc. 1994 Jun;26(3):1248. No abstract available.

PMID:
8029899
39.

Coordinate functions of multiple complement regulating molecules, CD46, CD55, and CD59.

Loveland BE, Szokolai K, Johnstone RW, McKenzie IF.

Transplant Proc. 1994 Jun;26(3):1070-1. No abstract available.

PMID:
7518104
40.

Upregulation of complement regulators MCP (CD46), DAF (CD55) and protectin (CD59) in arthritic joint disease.

Davies ME, Horner A, Loveland BE, McKenzie IF.

Scand J Rheumatol. 1994;23(6):316-21.

PMID:
7528443
41.

Antisense oligonucleotides decrease expression of human CD46, a regulator of complement.

Milland J, Loveland BE, Russell SM, McKenzie IF.

Transplant Proc. 1993 Oct;25(5):2922-3. No abstract available.

PMID:
8212285
42.

Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing.

Johnstone RW, Russell SM, Loveland BE, McKenzie IF.

Mol Immunol. 1993 Oct;30(14):1231-41.

PMID:
7692239
43.

Identification and quantification of complement regulator CD46 on normal human tissues.

Johnstone RW, Loveland BE, McKenzie IF.

Immunology. 1993 Jul;79(3):341-7.

44.

Autoreactive MHC-restricted cytotoxic cells in BALB/c mice after novel immunisation with a conserved mammalian autoantigen.

Karanikas V, Mackay IR, Rowley MJ, Loveland BE.

Cell Immunol. 1993 Apr 15;148(1):166-76.

PMID:
8495485
45.

CD46 (MCP) confers protection from lysis by xenogeneic antibodies.

Loveland BE, Johnstone RW, Russell SM, Thorley BR, McKenzie IF.

Transplant Proc. 1993 Feb;25(1 Pt 1):396-7. No abstract available.

PMID:
8438351
46.

Isolation of a clone for pig beta 2-microglobulin cDNA.

Milland J, Loveland BE, McKenzie IF.

Immunogenetics. 1993;38(6):464. No abstract available.

PMID:
8406623
47.

Different membrane cofactor protein (CD46) isoforms protect transfected cells against antibody and complement mediated lysis.

Loveland BE, Johnstone RW, Russell SM, Thorley BR, McKenzie IF.

Transpl Immunol. 1993;1(2):101-8.

PMID:
8081768
48.

Differing epitope selection of experimentally-induced and natural antibodies to a disease-specific autoantigen, the E2 subunit of pyruvate dehydrogenase complex (PDC-E2).

Rowley MJ, Maeda T, Mackay IR, Loveland BE, McMullen GL, Tribbick G, Bernard CC.

Int Immunol. 1992 Nov;4(11):1245-53.

PMID:
1282029
49.

Tissue-specific expression of CD46 isoforms.

Johnstone RW, Russell SM, Loveland BE, Jayasuriya N, McKenzie IF.

Transplant Proc. 1992 Oct;24(5):2331-2. No abstract available.

PMID:
1413083
50.

Functional characterisation of alternatively spliced CD46 cytoplasmic tails.

Russell SM, Loveland BE, Johnstone RW, Thorley BR, McKenzie IF.

Transplant Proc. 1992 Oct;24(5):2329-30. No abstract available.

PMID:
1413082

Supplemental Content

Loading ...
Support Center